Showing results (3381-3390 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|April 12, 2012
Tamoxifen alters the plasma concentration of molecules associated with cardiovascular risk in women with breast cancer undergoing chemotherapyWalckiria G Romero, Fabrício B Da Silva, Mariana V Borgo, et al.
The Oncologist|April 6, 2012
Hypophysitis induced by monoclonal antibodies to cytotoxic T lymphocyte antigen 4: challenges from a new cause of a rare diseaseFrancesco Torino, Agnese Barnabei, Liana De Vecchis, et al.
The Oncologist|April 6, 2012
The European Medicines Agency review of cabazitaxel (Jevtana®) for the treatment of hormone-refractory metastatic prostate cancer: summary of the scientific assessment of the committee for medicinal products for human useElias Pean, Pierre Demolis, Alexandre Moreau, et al.
The Oncologist|November 4, 2011
Novel therapeutic strategies for metastatic prostate cancer in the post-docetaxel settingOliver Sartor, Ross M Michels, Christophe Massard, et al.
The Oncologist|December 8, 2011
Triple-negative subtype predicts poor overall survival and high locoregional relapse in inflammatory breast cancerJing Li, Ana M Gonzalez-Angulo, Pamela K Allen, et al.
The Oncologist|December 8, 2011
When to wait for more evidence? Real options analysis in proton therapyJanneke P C Grutters, Keith R Abrams, Dirk de Ruysscher, et al.
The Oncologist|December 7, 2011
Impact of HER-2 overexpression/amplification on the prognosis of gastric cancer patients undergoing resection: a single-center study of 1,036 patientsJun-Te Hsu, Tse-Ching Chen, Jeng-Hwei Tseng, et al.
The Oncologist|December 20, 2011
Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotypingDarrell R Borger, Kenneth K Tanabe, Kenneth C Fan, et al.
The Oncologist|December 3, 2011
The outcomes and safety of single-agent sorafenib in the treatment of elderly patients with advanced hepatocellular carcinoma (HCC)Hilda Wong, Yuen Fong Tang, Tzy-Jyun Yao, et al.
The Oncologist|February 16, 2012
Retinopathy associated with adjuvant high-dose interferon-α2b in a patient with resected melanoma: a case report and review of the literatureJose G Monzon, Nazik Hammad, Samuel D Stevens, et al.
Pageof 571